After years of redefining itself as a telecom equipment provider, Nokia may finally be ready for a stock price breakout.

First surgeon-reported case using RECELL®, PermeaDerm®, and Cohealyx™ together in a single care pathwayNew clinical and tissue-level data on PermeaDerm and Cohealyx highlight wound bed preparation and ...

The company has devices under management across the world and has built a £16 million turnover. Here, Dave Weidner, describes the journey to get there and next steps in our Q&A.